ClearWay Rx Readmission Registry
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Abciximab (Primary) ; Eptifibatide (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 26 Jan 2016 Status changed from recruiting to completed as per the ClinicalTrials.gov record.
- 23 May 2013 Planned End Date changed from 1 Dec 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 31 Aug 2012 New trial record